131 related articles for article (PubMed ID: 7318049)
1. Effect of 1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) on leukocytes I. Analysis of the in vitro migration of human neutrophils.
Czarnetzki BM; Benveniste J
Chem Phys Lipids; 1981 Dec; 29(4):317-26. PubMed ID: 7318049
[TBL] [Abstract][Full Text] [Related]
2. Saturated and unsaturated 1-O-alkyl-2-O-acetoyl-sn-glycero-3-phosphocholines derived from ratfish liver oil: effect on human leukocyte migration.
Czarnetzki BM; Muramatsu T
Chem Phys Lipids; 1981 Dec; 29(4):309-15. PubMed ID: 7318048
[TBL] [Abstract][Full Text] [Related]
3. Effect of synthetic PAF-acether on human neutrophil function.
Czarnetzki BM; Benveniste J
Agents Actions; 1981 Dec; 11(6-7):549-50. PubMed ID: 7041568
[TBL] [Abstract][Full Text] [Related]
4. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Herrmann DB; Ferber E; Munder PG
Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor (PAF-acether), an activator of neutrophil functions.
Jouvin-Marche E; Poitevin B; Benveniste J
Agents Actions; 1982 Dec; 12(5-6):716-20. PubMed ID: 6299078
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
[TBL] [Abstract][Full Text] [Related]
7. Failure of PAF-acether to induce in vivo neutrophil migration.
Cunha FQ; Heluy-Neto NE; Klein A; Souza GE; Ferreira SH
Agents Actions; 1988 Aug; 25(1-2):191-4. PubMed ID: 3055873
[TBL] [Abstract][Full Text] [Related]
8. Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer.
Hopkins NK; Schaub RG; Gorman RR
Biochim Biophys Acta; 1984 Sep; 805(1):30-6. PubMed ID: 6089913
[TBL] [Abstract][Full Text] [Related]
9. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of platelet-activating factor (PAF)acether). III. Formation of PAF-acether from synthetic substrates by stimulated murine macrophages.
Mencia-Huerta JM; Roubin R; Morgat JL; Benveniste J
J Immunol; 1982 Aug; 129(2):804-8. PubMed ID: 7086143
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
[TBL] [Abstract][Full Text] [Related]
12. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.
Smiley PL; Stremler KE; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 1991 Jun; 266(17):11104-10. PubMed ID: 1645725
[TBL] [Abstract][Full Text] [Related]
13. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
Keraly CL; Benveniste J
Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
[TBL] [Abstract][Full Text] [Related]
14. Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets.
Ostermann G; Till U; Thielmann K
Thromb Res; 1984 Feb; 33(4):409-18. PubMed ID: 6710440
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of paf-acether: VIII: Impairment of paf-acether production in activated macrophages does not depend upon acetyltransferase activity.
Roubin R; Dulioust A; Haye-Legrand I; Ninio E; Benveniste J
J Immunol; 1986 Mar; 136(5):1796-802. PubMed ID: 3950403
[TBL] [Abstract][Full Text] [Related]
16. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
[TBL] [Abstract][Full Text] [Related]
17. Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets.
Kloprogge E; Akkerman JW
Biochem J; 1984 Nov; 223(3):901-9. PubMed ID: 6150705
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced fibrinogen binding to human platelets.
Kloprogge E; Mommersteeg M; Akkerman JW
J Biol Chem; 1986 Aug; 261(24):11071-6. PubMed ID: 3015954
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
[TBL] [Abstract][Full Text] [Related]
20. Effect of platelet activating factor on leukocytes. II. Enhancement of eosinophil chemotactic factor and beta-glucuronidase release.
Czarneztki BM
Chem Phys Lipids; 1982 Oct; 31(2):205-11. PubMed ID: 6814773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
